Consider this scenario, now playing out in clinics across the country: A veterinarian reviews a set of canine thoracic radiographs. Their AI radiology overlay, boasting a 95% accuracy rate, fails to flag a subtle interstitial lung pattern. Trusting the combination of their own review and the AI's silence, the veterinarian diagnoses a mild bronchitis. The dog's condition worsens, and a later review by a specialist reveals a missed, early-stage neoplasia. A malpractice claim follows. The question is no longer simple: who is responsible?
As artificial intelligence transitions from a novel technology to a standard component of the clinical toolkit, it is creating a profound legal and ethical gray area. This "liability vacuum" presents one of the most significant, unaddressed risks for practice owners in 2025.
AI and the Shifting "Standard of Care"
Veterinary malpractice is legally defined by a deviation from the "standard of care"—what a reasonably prudent veterinarian would do in similar circumstances. Historically, this standard was set by professional consensus, academic teaching, and expert testimony. AI complicates this in two ways:
- Is using AI now the standard of care? As AI diagnostic tools become more accessible and accurate, a future plaintiff could argue that *not* using an available AI to check for subtle findings is a failure to meet the standard of care.
- How does a vet prudently rely on AI? Conversely, can a veterinarian be held negligent for over-relying on an AI's output, especially if it contradicts their own clinical judgment?
Currently, the guidance from regulatory bodies like the AVMA is clear but general: AI is a tool to support, not replace, the veterinarian's professional judgment and the Veterinarian-Client-Patient Relationship (VCPR). This places the ultimate responsibility squarely on the clinician's shoulders.
Lessons from Human Medicine: The "Captain of the Ship" Doctrine
The human healthcare sector, which is further ahead in AI adoption, provides a useful model. The FDA's "Software as a Medical Device" (SaMD) framework regulates these tools, but the prevailing legal doctrine holds that the human physician is the "captain of the ship." They are expected to critically evaluate the AI's output, understand its limitations, and make the final clinical decision. This principle is almost certain to be the default legal position in veterinary medicine.
"The most significant legal mistake a practice can make is viewing AI as an oracle. It is a powerful, sophisticated, but ultimately fallible instrument. It provides data, not diagnosis. The final diagnosis remains the sole purview of the licensed veterinarian."
A Framework for Responsible AI Implementation & Risk Mitigation
While the legal landscape evolves, practice owners are not helpless. Proactive governance is the key to minimizing liability. A robust internal strategy should include four key pillars:
1. Rigorous Vendor Due Diligence
Before purchasing any AI tool, demand transparency from the vendor. Ask for data on their training models, accuracy rates in real-world studies (not just marketing materials), and information on how they handle data privacy and security. Choose vendors who see themselves as partners in patient care, not just software sellers.
2. Updated Informed Consent Protocols
Your client consent forms should be updated to include language about the use of AI technologies as part of the diagnostic process. This transparency builds trust and manages client expectations about the tools being used to support—but not replace—the veterinarian's expertise.
3. Documented Standard Operating Procedures (SOPs)
Create clear, written policies for how AI tools are to be used in your clinic. For example, an SOP for an AI radiology tool might state: "The AI report is to be used as a preliminary screening tool. The final interpretation and diagnosis must be made and signed off by the attending veterinarian in the medical record." This proves you have a structured, safety-oriented process.
4. Continuous Staff Training and Competency Assessment
Ensure your entire clinical team is trained not only on how to use the AI tool, but also on its known limitations. Document this training. Demonstrating that your staff is competent and understands the technology's boundaries is a powerful defense against claims of negligence.
Conclusion
The integration of AI into veterinary medicine is an irreversible and overwhelmingly positive trend. However, it introduces new categories of risk that cannot be ignored. The liability vacuum is real, but it is not unmanageable. By treating AI as a powerful medical instrument—subject to the same rigorous standards of validation, training, and professional oversight as any other clinical tool—practice owners can confidently harness its power while protecting their patients, their teams, and their businesses.
References
- American Veterinary Medical Association (AVMA): "Artificial intelligence in veterinary medicine" - https://www.avma.org/resources-tools/business-practice/artificial-intelligence-veterinary-medicine
- U.S. Food & Drug Administration (FDA): "Software as a Medical Device (SaMD)" - https://www.fda.gov/medical-devices/digital-health-center-excellence/software-medical-device-samd
- Journal of the American Veterinary Medical Association (JAVMA): "Legal and ethical issues in veterinary telemedicine" - https://avmajournals.avma.org/view/journals/javma/257/1/javma.257.1.59.xml